Showing results (201-210 of 420) with videos related to
Sort By:
Pageof 42
Der Internist|December 30, 2006
[Nuclear medical diagnostics for liver tumors]A K Buck, J C Stollfuss, A Stahl, et al.EJNMMI Physics|January 16, 2026
[177Lu]Lu-DOTA-TATE tumour and organ time-activity curves: prediction from a single-time-point [68Ga]Ga-DOTA-TATE PET/CT measurementValentina Vasić, Johan Gustafsson, Elham Yousefzadeh-Nowshahr, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE TherapyPeter Kletting, Thomas Kull, Christian Maaß, et al.Journal of Leukocyte Biology|May 1, 1994
Serotonin-stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factorM F Katz, H W Farber, Z Dodds-Stitt, et al.Oncotargets and Therapy|July 15, 2014
Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphomaSimon Heidegger, Ambros J Beer, Eva Geissinger, et al.Journal of Cell Science|February 14, 2016
TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in miceLaiqun Zhang, Ken Blackwell, Lauren M Workman, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2017
Prospective head-to-head comparison of 11C-choline-PET/MR and 11C-choline-PET/CT for restaging of biochemical recurrent prostate cancerMatthias Eiber, Isabel Rauscher, Michael Souvatzoglou, et al.Scientific Reports|December 29, 2019
The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK modelNusrat J Begum, Gerhard Glatting, Hans-Jürgen Wester, et al.Cellular Immunology|April 1, 1983
Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF)R E Rocklin, I Kiselis, D J Beer, et al.Cellular Immunology|October 1, 1985
Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subsetJ S Berman, W W Cruikshank, D M Center, et al.Pageof 42